Uray Pharmaceuticals operates as a professional pharmaceutical firm based in Shanghai, with a focus on introducing and advancing global innovative medications and marketing them in Greater China and the Asia-Pacific region. By bringing in patents, they establish a pharmaceutical product pipeline in Greater China and the Asia-Pacific region, and develop a comprehensive commercial presence, enabling them to enter diverse therapeutic fields in the expansive Chinese market. They possess an exceptional clinical and registration team, proactive business development drivers, and an integrated business platform.